Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab versus standard Treatment in subjects with recurrent or metastatic Head and Neck Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I